SquamousCellCarcinomaofSkin near Brick, NJ
We found 1,780 results within 50 miles for "SquamousCellCarcinomaofSkin near Brick, NJ"
- Offers Telehealth


- Offers Telehealth


- Offers Telehealth
Care Philosophy: Cancer diagnosis is an extremely challenging time for patients I strive to provide comprehensive evidence based treatment and helping them navigate through this phase while maintaining quality of life

- Offers Telehealth
Care Philosophy: Where Care and Compassion Matters


- Offers Telehealth

- Offers Telehealth
Biography: Dr. Christian Rolfo, MD is an Oncology Specialist who practices in New York, NY. Dr. Christian Rolfo, MD is affiliated with Mount Sinai Morningside, Mount Sinai Queens and Mount Sinai Brooklyn.


- Offers Telehealth



- Offers Telehealth

- Offers Telehealth

- Offers Telehealth

- Offers Telehealth


- Offers Telehealth

- Offers Telehealth

- Offers Telehealth
Biography: Dr. Uqba Khan is an Assistant Professor of Clinical Medicine within the faculty of Weill Cornell Medical College in the Division of Hematology and Medical Oncology. Dr. Khan is also an Attending Physician at NewYork-Presbyterian Brooklyn Methodist Hospital.Dr. Khan received his medical degree from Allama Iqbal Medical College, Pakistan in 2008. He underwent his internal medicine training at St. Agnes Hospital in Baltimore and later completed his hematology/oncology fellowship at St. John Hospital and Medical Center in Detroit, where he also served as chief fellow. Dr. Khan has a special interest in treatment of gastrointestinal (GI) malignancies and clinical research. He joined Weill Cornell Medicine in 2018 to complete an additional year of training in management of gastrointestinal malignancies. He also worked as an instructor at Weill Cornell Medical College between 2018 and 2019. In June of 2019, Dr. Khan was promoted to Assistant Professor of Clinical Medicine within the faculty of Weill Cornell Medical College in the Division of Hematology and Medical Oncology.Dr. Khan has been involved in a number of clinical and translational research studies. His research focuses on optimizing the effectiveness of immunotherapy in solid malignancies. He has published a number of research articles and is actively involved as an investigator in several clinical trials. He has presented his research findingsat several professional conferences and meetings.Dr. Khan is a member of several national and international professional societies, including the American Society of Clinical Oncology (ASCO), the Society of Immunotherapy in Cancer (SITC), the European Society of Medical Oncology (ESMO) and the American Association for Cancer Research (AACR).

